Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002891902 | SCV003644970 | uncertain significance | Inborn genetic diseases | 2022-09-06 | criteria provided, single submitter | clinical testing | The c.4426C>G (p.Q1476E) alteration is located in exon 29 (coding exon 29) of the PIEZO2 gene. This alteration results from a C to G substitution at nucleotide position 4426, causing the glutamine (Q) at amino acid position 1476 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |